Unlocking Sheldon-Hall Syndrome: A Family's Genetic Journey
"Exploring a rare TPM2 mutation and its impact on distal arthrogryposis"
Sheldon-Hall syndrome (SHS), also known as distal arthrogryposis type 2B, is a rare genetic condition characterized by congenital joint contractures, primarily affecting the limbs. Unlike other forms of arthrogryposis, SHS doesn't involve primary neurological issues. Common features include contractures in the distal limb joints, leading to camptodactyly (弯曲指), clubfeet, a triangular face, distinct facial features such as downslanting palpebral fissures, a small mouth, prominent nasolabial folds, and a high arched palate.
SHS is a genetically heterogeneous disorder, meaning it can be caused by mutations in different genes. It's distinguished from Freeman-Sheldon syndrome (FSS) by the absence of severe orofacial muscle contractures, making SHS generally a less severe condition. While the prevalence of arthrogryposis is estimated at 1 in 3,000 births, SHS remains exceptionally rare, with fewer than 100 cases reported in medical literature.
This article presents the first documented case of a Korean family spanning two generations affected by SHS resulting from a rare mutation in the TPM2 gene. We'll explore the clinical presentation of this family, the diagnostic journey, and the implications of this genetic finding.
The TPM2 Mutation and Its Impact
The affected individuals in this family, a mother and her daughter, exhibit typical features of SHS. The daughter was referred to the Seoul National University Children's Hospital as a one-month-old, for evaluation of multiple congenital contractures of both hands and feet. Prenatal ultrasounds had already indicated bilateral clenched hands and talipes equinovarus (clubfoot).
- Clinical Presentation: Triangular face, downslanting palpebral fissures, small mouth, high arched palate, prominent nasolabial folds.
- Limb Deformities: Camptodactyly (bent fingers), clubfoot, talocalcaneal coalition (fusion of bones in the ankle).
- Genetic Confirmation: The family's SHS was confirmed through genetic testing, which revealed a rare TPM2 mutation (p.R133W) in both the mother and daughter.
Implications and Future Directions
This case underscores the importance of considering TPM2 mutations in individuals presenting with SHS, especially when MYH3 mutations are absent. Accurate diagnosis is crucial for appropriate management and genetic counseling. Given the autosomal dominant inheritance pattern, families have a 50% chance of recurrence.
Although SHS is rare, the potential for progressive motor weakness and associated feeding difficulties, as seen in the infant patient, necessitates close monitoring and proactive intervention. The family received genetic counseling, and the mother is considering prenatal genetic diagnosis in future pregnancies.
Further research is needed to fully elucidate the mechanisms by which TPM2 mutations lead to congenital contractures and to develop targeted therapies for individuals with SHS. Long-term follow-up of affected individuals is essential to monitor the progression of muscle weakness and address any associated complications.